IONS insider files to sell 60,846 shares

IONS insider filing for proposed sale of 60,846 shares.

Rhea-AI Filing Summary

IONS insider filing for proposed sale of 60,846 shares. The filing shows a proposed disposition by Holly Kordasiewicz of 60,846 shares of Common Stock dated 06/12/2026 with an aggregate value of $4,466,425. The securities were originally granted as Restricted Stock on 01/15/2021.

Insights

Securities Counsel

Routine Form 144 notice of proposed resale by an insider.

The filing documents a proposed sale of 60,846 shares valued at $4,466,425 on 06/12/2026

Form 144 is a procedural notice required before public resale of restricted/controlled shares; cash‑flow treatment and whether sales occurred are not stated here.

Key Figures

Proposed shares to sell: 60,846 shares Aggregate value: $4,466,425 Grant date: 01/15/2021

3 metrics

Proposed shares to sell 60,846 shares Disposition date <date>06/12/2026</date>

Aggregate value $4,466,425 Value reported for the 60,846 shares

Grant date 01/15/2021 Original restricted stock grant date

Key Terms

Form 144, Restricted Stock, Equity Compensation

3 terms

Form 144 regulatory

"Proposed disposition notice for sale of restricted/controlled securities"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock financial

"Securities To Be Sold | Restricted Stock | Issuer | 01/15/2021"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Equity Compensation financial

"01/15/2021 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the IONS Form 144 filed by Holly Kordasiewicz report?

It reports a proposed resale of 60,846 shares of Common Stock on 06/12/2026. The filing shows an aggregate value of $4,466,425 and notes the shares were restricted stock granted on 01/15/2021.

Does the Form 144 mean the shares were already sold for IONS (IONS)?

No; Form 144 is a notice of proposed resale and does not itself confirm a completed sale. It provides the insider's intent to sell restricted/controlled shares but not final transaction details or settlement information.

How many shares and what value are listed in the IONS Form 144 filing?

The filing lists 60,846 shares with an aggregate value of $4,466,425. The date associated with the disposition in the filing is 06/12/2026 and the shares were from a 01/15/2021 restricted stock grant.

What type of securities are covered in this IONS Form 144 filing?

The filing covers Common Stock originally issued as Restricted Stock under an equity compensation grant dated 01/15/2021. The form lists the proposed resale of those restricted/controlled shares.

Who receives proceeds from the sale reported on the IONS Form 144?

The filing does not state who receives proceeds. Form 144 reports a proposed insider resale; specific cash‑flow recipients or settlement details are not provided in this excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/07/2026 - 04:30 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002102721
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IONIS PHARMACEUTICALS INC
SEC File Number	000-19125
Address of Issuer	2855 GAZELLE COURT CARLSBAD CALIFORNIA 92010
Phone	7609319200
Name of Person for Whose Account the Securities are To Be Sold	Kordasiewicz Holly B.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	1287	108494.00	165262556	07/07/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/15/2021	Restricted Stock	Issuer			1287	01/15/2021	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Holly Kordasiewicz 2855 GAZELLE COURT CARLSBAD CA 92010	Common Stock	06/12/2026	60846	4466425.00

144: Remarks and Signature

Remarks
Date of Notice	07/07/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Weimer, as a duly authorized representative of STIFEL, as attorney-in-fact for Holly Kordasiewicz
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)